NEW YORK (GenomeWeb News) – Seegene said today that Health Canada has approved two of its multiplex diagnostic tests for respiratory infections.
Health Canada awarded Medical Device Licenses for the company’s PCR-based Seeplex RV5 Auto Capillary Electrophoresis Screening and RV12 Auto Capillary Electrophoresis Detection tests.
The Seeplex RV5 test detects influenza A, influenza B, and respiratory syncytial virus A/B, and screens for 11 viruses; while the RV12 test identifies 12 viruses individually.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.